Market Cap 588.34M
Revenue (ttm) 418.63M
Net Income (ttm) 48.58M
EPS (ttm) N/A
PE Ratio 11.47
Forward PE 111.43
Profit Margin 11.60%
Debt to Equity Ratio 0.01
Volume 662,400
Avg Vol 1,564,252
Day's Range N/A - N/A
Shares Out 148.95M
Stochastic %K 81%
Beta 1.45
Analysts Strong Sell
Price Target $6.60

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
Monticello4
Monticello4 Jul. 2 at 7:30 PM
0 · Reply
Mobagri
Mobagri Jul. 2 at 5:28 PM
$MDXG what a fucking idiot. He calls himself a professional. Yeah a professional pimp to his wife. Dumb cocksucker
0 · Reply
Monticello4
Monticello4 Jul. 2 at 4:34 PM
$MDXG here is the true character of the scum Mobagri---he cannot discuss, learn, think, or act like an adult...perfect example of very low IQ
1 · Reply
Mobagri
Mobagri Jul. 2 at 4:16 PM
$MDXG no wonder his woman is out and about selling herself.
0 · Reply
eeyore152
eeyore152 Jul. 2 at 2:49 PM
$MDXG Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P) is out. What that means for Skin Substitutes: The CY 2027 proposal is largely a "hold year" for skin substitutes: * No reduction to the $127.14/cm² group payment rate proposed. * No new payment methodology. * ASC separate payment preserved. * CMS explicitly indicates major rate recalibration will likely wait until CY 2028, once enough CY 2026 claims experience is available. https://www.cms.gov/newsroom/fact-sheets/calendar-year-2027-hospital-outpatient-prospective-payment-system-opps-ambulatory-surgical-center
0 · Reply
Monticello4
Monticello4 Jul. 2 at 11:06 AM
$MDXG ...
1 · Reply
Monticello4
Monticello4 Jul. 2 at 11:05 AM
0 · Reply
Monticello4
Monticello4 Jul. 2 at 11:04 AM
1 · Reply
Mobagri
Mobagri Jul. 1 at 9:47 PM
$MDXG star employee
0 · Reply
Monticello4
Monticello4 Jul. 1 at 3:15 PM
$MDXG Faggy Mobaggy says...
0 · Reply
Latest News on MDXG
MiMedx Group Transcript: AGM 2026

Jun 10, 2026, 9:00 AM EDT - 24 days ago

MiMedx Group Transcript: AGM 2026


MIMEDX Announces Launch of G4Derm® Plus

May 8, 2026, 8:00 AM EDT - 2 months ago

MIMEDX Announces Launch of G4Derm® Plus


MiMedx price target lowered to $6 from $7 at Craig-Hallum

2026-04-30T15:00:20.000Z - 2 months ago

MiMedx price target lowered to $6 from $7 at Craig-Hallum


MiMedx price target lowered to $6 from $7 at Citizens

2026-04-30T09:56:05.000Z - 2 months ago

MiMedx price target lowered to $6 from $7 at Citizens


MiMedx reports Q1 adjusted EPS (5c), consensus (4c)

2026-04-29T20:49:58.000Z - 2 months ago

MiMedx reports Q1 adjusted EPS (5c), consensus (4c)


MiMedx Group Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

MiMedx Group Earnings Call Transcript: Q1 2026


MiMedx Group Quarterly report: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

MiMedx Group Quarterly report: Q1 2026


MiMedx Group Earnings release: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

MiMedx Group Earnings release: Q1 2026


MiMedx Group Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

MiMedx Group Proxy statement: Proxy filing


MiMedx Group Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

MiMedx Group Proxy statement: Proxy filing


MiMedx price target lowered to $7 from $10 at Citizens

2026-04-20T09:40:37.000Z - 2 months ago

MiMedx price target lowered to $7 from $10 at Citizens


MiMedx price target lowered to $7 from $10 at Citizens

2026-04-17T19:06:41.000Z - 2 months ago

MiMedx price target lowered to $7 from $10 at Citizens


MiMedx price target lowered to $6 from $10 at Northland

2026-04-17T13:24:00.000Z - 2 months ago

MiMedx price target lowered to $6 from $10 at Northland


MiMedx price target lowered to $7 from $10 at Craig-Hallum

2026-04-17T13:10:22.000Z - 2 months ago

MiMedx price target lowered to $7 from $10 at Craig-Hallum


MiMedx announces restructuring, cost reduction initiatives

2026-04-16T13:23:44.000Z - 2 months ago

MiMedx announces restructuring, cost reduction initiatives


MIMEDX Announces Restructuring and Cost Reduction Initiative

Apr 16, 2026, 8:00 AM EDT - 2 months ago

MIMEDX Announces Restructuring and Cost Reduction Initiative


MIMEDX to Sponsor Leading Advanced Wound Care Conferences

Apr 2, 2026, 9:15 AM EDT - 3 months ago

MIMEDX to Sponsor Leading Advanced Wound Care Conferences


MIMEDX Announces Launch of CHORIOFIX™

Mar 23, 2026, 8:00 AM EDT - 3 months ago

MIMEDX Announces Launch of CHORIOFIX™


MiMedx announces commercial launch of AMNIOFIX Thyroid Shields

2026-03-05T13:20:46.000Z - 4 months ago

MiMedx announces commercial launch of AMNIOFIX Thyroid Shields


MiMedx Group Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

MiMedx Group Earnings Call Transcript: Q4 2025


MiMedx Group Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

MiMedx Group Earnings release: Q4 2025


MiMedx Group Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

MiMedx Group Annual report: Q4 2025


MiMedx reports Q4 adjusted EPS 14c, consensus 11c

2026-02-25T21:06:51.000Z - 4 months ago

MiMedx reports Q4 adjusted EPS 14c, consensus 11c


MiMedx sees FY26 revenue $340M-$360M, consensus $356.17M

2026-02-25T21:05:57.000Z - 4 months ago

MiMedx sees FY26 revenue $340M-$360M, consensus $356.17M


MiMedx initiated with an Outperform at Citizens

2026-02-23T09:45:23.000Z - 4 months ago

MiMedx initiated with an Outperform at Citizens


MiMedx price target lowered to $8 from $12 at Cantor Fitzgerald

2026-02-17T13:15:52.000Z - 4 months ago

MiMedx price target lowered to $8 from $12 at Cantor Fitzgerald


MiMedx price target lowered to $10 from $13 at Craig-Hallum

2026-01-23T14:16:32.000Z - 5 months ago

MiMedx price target lowered to $10 from $13 at Craig-Hallum


MiMedx price target lowered to $10 from $12 at Northland

2026-01-20T14:10:19.000Z - 5 months ago

MiMedx price target lowered to $10 from $12 at Northland


MiMedx price target lowered to $10 from $12 at Lake Street

2026-01-20T13:51:36.000Z - 5 months ago

MiMedx price target lowered to $10 from $12 at Lake Street


MIMEDX to Participate in Upcoming Investor Conferences

Nov 10, 2025, 4:01 PM EST - 8 months ago

MIMEDX to Participate in Upcoming Investor Conferences


MiMedx Group Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 8 months ago

MiMedx Group Earnings Call Transcript: Q3 2025


MiMedx Group Earnings release: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 8 months ago

MiMedx Group Earnings release: Q3 2025


MiMedx Group Quarterly report: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 8 months ago

MiMedx Group Quarterly report: Q3 2025


MIMEDX Announces Record Revenue for Third Quarter 2025

Oct 29, 2025, 4:01 PM EDT - 8 months ago

MIMEDX Announces Record Revenue for Third Quarter 2025


MIMEDX Announces Launch of EPIXPRESS®

Oct 6, 2025, 9:28 AM EDT - 9 months ago

MIMEDX Announces Launch of EPIXPRESS®


MiMedx Group Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings Call Transcript: Q2 2025


MiMedx Group Earnings release: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings release: Q2 2025


MiMedx Group Quarterly report: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

MiMedx Group Quarterly report: Q2 2025


MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

Jul 30, 2025, 8:00 AM EDT - 1 year ago

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.


MiMedx Group Proxy statement: Proxy Filing

May 23, 2025, 8:00 AM EDT - 1 year ago

MiMedx Group Proxy statement: Proxy Filing


MiMedx Group Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings Call Transcript: Q1 2025


MiMedx Group Earnings release: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings release: Q1 2025


MiMedx Group Quarterly report: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

MiMedx Group Quarterly report: Q1 2025


MiMedx Group Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

MiMedx Group Proxy statement: Proxy Filing


MiMedx Group Slides: Investor Presentation

Apr 30, 2025, 7:00 AM EDT - 1 year ago

MiMedx Group Slides: Investor Presentation


MiMedx Group Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MiMedx Group Earnings Call Transcript: Q4 2024


MiMedx Group Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MiMedx Group Earnings release: Q4 2024


MiMedx Group Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MiMedx Group Annual report: Q4 2024


MiMedx Group Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 9:45 AM EST - 1 year ago

MiMedx Group Transcript: Stifel 2024 Healthcare Conference


MiMedx Group Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings Call Transcript: Q3 2024


MiMedx Group Earnings release: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings release: Q3 2024


MiMedx Group Quarterly report: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

MiMedx Group Quarterly report: Q3 2024


MiMedx Group Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Earnings Call Transcript: Q2 2024


MiMedx Group Quarterly report: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Quarterly report: Q2 2024


MiMedx Group Earnings release: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Earnings release: Q2 2024


MiMedx Group Slides: Investor Presentation

May 1, 2024, 9:00 AM EDT - 2 years ago

MiMedx Group Slides: Investor Presentation


MiMedx Group Earnings Call Transcript: Q1 2024

Apr 30, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Earnings Call Transcript: Q1 2024


MiMedx Group Quarterly report: Q1 2024

Apr 30, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Quarterly report: Q1 2024


MiMedx Group Earnings release: Q1 2024

Apr 30, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Earnings release: Q1 2024


MiMedx Group Slides: Q1 2024

Apr 30, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Slides: Q1 2024


MiMedx Group Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

MiMedx Group Proxy statement: Proxy Filing


MiMedx Group Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

MiMedx Group Proxy statement: Proxy Filing


MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Mar 20, 2024, 7:00 AM EDT - 2 years ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing


MiMedx Group Earnings Call Transcript: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

MiMedx Group Earnings Call Transcript: Q4 2023


MiMedx Group Annual report: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

MiMedx Group Annual report: Q4 2023


MiMedx Group Earnings release: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

MiMedx Group Earnings release: Q4 2023


Monticello4
Monticello4 Jul. 2 at 7:30 PM
0 · Reply
Mobagri
Mobagri Jul. 2 at 5:28 PM
$MDXG what a fucking idiot. He calls himself a professional. Yeah a professional pimp to his wife. Dumb cocksucker
0 · Reply
Monticello4
Monticello4 Jul. 2 at 4:34 PM
$MDXG here is the true character of the scum Mobagri---he cannot discuss, learn, think, or act like an adult...perfect example of very low IQ
1 · Reply
Mobagri
Mobagri Jul. 2 at 4:16 PM
$MDXG no wonder his woman is out and about selling herself.
0 · Reply
eeyore152
eeyore152 Jul. 2 at 2:49 PM
$MDXG Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P) is out. What that means for Skin Substitutes: The CY 2027 proposal is largely a "hold year" for skin substitutes: * No reduction to the $127.14/cm² group payment rate proposed. * No new payment methodology. * ASC separate payment preserved. * CMS explicitly indicates major rate recalibration will likely wait until CY 2028, once enough CY 2026 claims experience is available. https://www.cms.gov/newsroom/fact-sheets/calendar-year-2027-hospital-outpatient-prospective-payment-system-opps-ambulatory-surgical-center
0 · Reply
Monticello4
Monticello4 Jul. 2 at 11:06 AM
$MDXG ...
1 · Reply
Monticello4
Monticello4 Jul. 2 at 11:05 AM
0 · Reply
Monticello4
Monticello4 Jul. 2 at 11:04 AM
1 · Reply
Mobagri
Mobagri Jul. 1 at 9:47 PM
$MDXG star employee
0 · Reply
Monticello4
Monticello4 Jul. 1 at 3:15 PM
$MDXG Faggy Mobaggy says...
0 · Reply
Monticello4
Monticello4 Jul. 1 at 3:12 PM
$MDXG ...
0 · Reply
Monticello4
Monticello4 Jul. 1 at 3:11 PM
$MDXG smart girl
0 · Reply
Mobagri
Mobagri Jul. 1 at 12:13 PM
$MDXG if this guy is the star employee, this company is doomed.
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 29 at 8:34 PM
$MDXG Something big brewing.....
1 · Reply
Monticello4
Monticello4 Jun. 29 at 2:44 PM
$MDXG ...
0 · Reply
Monticello4
Monticello4 Jun. 29 at 2:44 PM
$MDXG ---------------..___________________
0 · Reply
Mobagri
Mobagri Jun. 29 at 2:26 PM
$MDXG Monticello the pro cocksucker employee
0 · Reply
GlobalInsights
GlobalInsights Jun. 29 at 1:17 PM
$MDXG Key question on SLS is does their Phase 3 Regal study pass or do a MDXG KOA and tank?
0 · Reply
Monticello4
Monticello4 Jun. 29 at 12:53 PM
$MDXG ...
0 · Reply
Monticello4
Monticello4 Jun. 29 at 12:53 PM
$MDXG perfection...😂
0 · Reply
GlobalInsights
GlobalInsights Jun. 29 at 12:23 PM
$MDXG Awhile back I suggested people on this board gave a look at SLS , well might want to look at the price chart on that. I exited MDXG to focus on SLS
0 · Reply
jmdaddy
jmdaddy Jun. 29 at 12:13 PM
$MDXG I know it's only pre-market but $4 looks awful good again. Hopefully this will be a sign of things to come.
0 · Reply